Home/Filings/4/0001628280-22-031872
4//SEC Filing

Vong John 4

Accession 0001628280-22-031872

CIK 0001083446other

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 6:11 PM ET

Size

10.6 KB

Accession

0001628280-22-031872

Insider Transaction Report

Form 4
Period: 2022-12-12
Vong John
SVP-Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2022-12-12+1,3885,159 total
  • Award

    Common Stock

    2022-12-12+1,3886,547 total
  • Award

    Common Stock

    2022-12-12+6947,241 total
  • Award

    Common Stock

    2022-12-12+6947,935 total
Footnotes (4)
  • [F1]Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on November 30, 2023 and upon achievement of a pre-established performance goal on or before April 1, 2023.
  • [F2]Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on November 30, 2023 and upon achievement of a pre-established performance goal on or before July 1, 2023.
  • [F3]Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, 519 shares shall vest in three equal annual installments beginning on November 30, 2023. The remaining 175 shall vest on November 30, 2026. Such vesting is subject to achievement of a pre-established performance goal on or before April 1, 2023.
  • [F4]Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, 519 shares shall vest in three equal annual installments beginning on November 30, 2023. The remaining 175 shall vest on November 30, 2026. Such vesting is subject to achievement of a pre-established performance goal on or before November 30, 2026.

Issuer

Apollo Medical Holdings, Inc.

CIK 0001083446

Entity typeother

Related Parties

1
  • filerCIK 0001572846

Filing Metadata

Form type
4
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 6:11 PM ET
Size
10.6 KB